Bixiye
Arikayce® (amikacin liposome inhalation) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2025
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 361 - 370 ee natiijooyinka 3167
Bixiye
Antifungals - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2025
Bixiye
Pseudobulbar Affect (PBA) - Medicaid
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2025
Bixiye
Pseudobulbar Affect (PBA) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2025
Bixiye
Zeposia® (ozanimod) - Medicaid
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2025
Bixiye
Xhance® (fluticasone propionate) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2025
Bixiye
DPP-4 (dipeptidyl peptidase-4) Inhibitors and Combinations - Commercial
Step Therapy, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2025
Bixiye
Coverage Exception - Commercial - NetResults Key Rx & Focus Rx
Coverage Exception
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2025
Bixiye
Sodium-glucose Co-transporter (SGLT) Inhibitors and Combinations - Commercial
Step Therapy, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2025
Bixiye
Sodium-glucose Co-transporter (SGLT) Inhibitor and Combinations - Medicaid
Step Therapy, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2025